A simple pressure pump, made from balloons and nylon stockings, means more people in more places will be able to test water contaminants and blood samples.
The ingenious device unveiled in the prestigious Lab on a Chip journal cost just $2 to make, yet works almost as well as its expensive and cumbersome lab counterparts.
Pumps are used to make biological samples flow through microfluidic devices while their contents are identified beneath a microscope.
This DIY pump came from a collaboration between researchers at RMIT University and the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, who demonstrated its viability in tests to detect aquatic parasites and cancer cells and to study vascular diseases.
Inspired by football
Study lead author and RMIT engineer, Dr Peter Thurgood,said the team took inspiration for the simple invention from footballs, which hold large pressures when reinforced.
“We started with basic latex balloons, then realised that regular stockings made from nylon and elastane could be a perfect match to reinforce them, allowing them to hold significantly higher pressure and function as pumps,” Thurgood said.
“By simply wrapping three layers of stockings around the latex balloon we were able to increase its internal pressure by a factor of 10 – enough to run many water or blood analyses that would usually require large, expensive pumps.”
Experiments showed the reinforced balloon pump could be used to operate microfluidic devices for several hours without a significant pressure loss.
The pump also fits easily within an incubator and can be left overnight.
A low-cost field tool where it’s needed most
Study co-author and parasitologist at the Walter and Eliza Hall Institute,Associate Professor Aaron Jex, is a leading researcher in global water quality and public health interventions.
He said this simple innovation opened exciting opportunities in field water testing and the ability to test and diagnose patients for infectious pathogens and aquatic micro-organisms at the point-of-care.
“Parasitic micro-organisms have a major impact in impoverished communities in tropical and subtropical regions globally, but also in developed countries including Australia,” Jex said.
“In order to address this there is an urgent need for field-based, low-cost diagnostic tools that work in challenging, sometimes remote and often complex environments very different from a pristine laboratory.”
“As simple as it may look, this device suits those needs really well and could have a big impact.”
Co-author and RMIT biologist, Dr Sara Baratchi, said it also had promising applications for early diagnosis of diseases at home or in the doctor’s surgery.
The balloon pump was tested as a point-of-care diagnostic device for detection of very low concentrations of target cancer cells in liquid samples, and found to work.
“The hydrodynamic force of liquid produced by the reinforced balloon was enough to isolate cells for study, which was really amazing for a $2 pump!”
Baratchi is now working on applying the simplified pump technology to develop organ-on-chip systems that mimic the flow conditions in dysfunctional vessels, to better understand diseases like atherosclerosis that lead to heart attack and stroke.
An opportunity for outreach
RMIT engineer and project leader, Dr Khashayar Khoshmanesh,is a leading researcher in the field of microfluidic based lab-on-a-chip technologies.
He said while microfluidics had made significant progress over the past decade, their widespread application had been limited by the cost and bulk of pumps required to operate them.
“Simplicity is at the heart of our entire research program. By redesigning sophisticated microfluidic devices into simplified ones, we can maximise their outreach and applications for use in teaching or research in the field, not just in sophisticated labs,” he said.
“We envisage these types of pumps also being suitable for student classwork experiments to support capability development in this important area of research from an earlier stage.”
The Latest on: Point-of-care diagnostic device
via Google News
The Latest on: Point-of-care diagnostic device
- Cardiac POC Testing Devices Marketon November 12, 2019 at 9:35 pm
Cardiac POC testing devices or point of care devices are mainly used for medical diagnostic tests. These tests are conducted at a time and place convenient for patient care. These cardiac POC devices ...
- Co-Diagnostics, Inc. (CODX)on November 12, 2019 at 1:01 pm
CoDx™ tests are a fraction of the cost of other DNA-based tests, designed for a new generation of affordable, mobile point-of-care diagnostic devices and compatible with many other devices, creating ...
- Novel Coating Makes Affinity-Based Sensors Practical for Medicineon November 11, 2019 at 9:53 am
This was tried with antibodies for interleukin 6 (IL6), insulin, or glucagon, which are all important biomolecules, and the device performed exceptionally well. The researchers believe that their ...
- An antifouling coating that enables affinity-based electrochemical biosensing in complex biological fluidson November 11, 2019 at 8:09 am
Affinity-based electrochemical detection in complex biological fluids could enable multiplexed point-of-care diagnostics for home healthcare; however, commercialization of point-of-care devices has ...
- Moving diagnostics out of the lab and into your handon November 11, 2019 at 8:02 am
They are actively exploring commercialization options for eRapid in the handheld point-of-care diagnostics space, but also hope to extend the coating and sensor technology platform to other targets ...
- Point of Care (PoC) Diagnostics Market Size is Expected to Exhibit 34.6 billion USD by 2025on November 8, 2019 at 8:09 am
utm_source=marketwatch.com&utm_medium=ADS Point of Care (PoC) diagnostics, are medical devices or tools that helps to diagnose the disease in patient’s community, usually outside of clinical labs. The ...
- Chembio Diagnostics Enters into Definitive Agreement to Acquire Orangelifeon November 7, 2019 at 12:03 pm
a privately-held Brazilian manufacturer and distributor of point-of-care diagnostics tests for infectious diseases ... ISO-certified and approved by ANVISA to produce Class II/III/IV medical devices.
- Point of Care (PoC) Diagnostics Market – Global Structure, Size, Trends, Analysis and Outlook 2019-2025on November 6, 2019 at 4:09 am
The global Point of Care (PoC) diagnostics market is anticipated to reach USD 34.6 billion by 2025. Point of Care (PoC) diagnostics, are medical devices or tools that helps to diagnose the disease in ...
- Innovation and better availability of medical devices can help India stay on top of its healthon November 6, 2019 at 12:48 am
Portable/point-of-care devices are an important category that have made it possible to improve diagnostic mechanisms at primary healthcare level, provide care at home and resulted in improved health ...
- ENDRA Life Sciences to Host Key Opinion Leader (KOL) Event in Conjunction with the Annual 2019 AASLD Liver Meetingon November 4, 2019 at 5:13 am
and nonalcoholic steatohepatitis (NASH), an overview of the landscape and describe the need for a point-of-care diagnostic device. A live audio webcast of the presentation will be available through ...
via Bing News